Notice of Change to Key Dates in RFA-HL-20-010 "BLOODSAFE (U24 Clinical Trial Not Allowed)"

Notice Number: NOT-HL-19-694

Key Dates
Release Date: April 12, 2019

Related Announcements

RFA-HL-20-009

RFA-HL-20-010

NOT-HL-19-691

Issued by
National Institutes of Health (NIH)

Purpose

On March 11, 2019, NHLBI issued RFA-HL-20-010, "BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (U24 Clinical Trial Not Allowed)”. The purpose of this Notice is to change the key dates.

Key Dates

Application Due Date(s)

Current Language:

May 20, 2019, by 5:00 PM local time of applicant organization.

Revised Language:

June 11, 2019, by 5:00 PM local time of applicant organization.

Scientific Merit Review

Current Language:

November 2019

Revised Language:

December 2019

Expiration Date

Current Language:

May 21, 2019

Revised Language

June 12, 2019

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Shimian Zou, PhD
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: shimian.zou@nih.gov

LeShawndra Price, PhD
Center for Translation Research and Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8166
Email: leshawndra.price@nih.gov